GlassScriptPhysician profile
Mohammad H Dorri
NPI 1366754293
$2,390.65
in general payments reported to CMS, 2019-2025
25 companies · $92.16 in 2025
The $92.16 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $446 · 2021: $778 · 2022: $444 · 2023: $167 · 2024: $236 · 2025: $92.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $770.63 | 2019-2024 | Proclaim, Eterna |
| Si-Bone, INC. | $181.48 | 2020-2022 | |
| Boston Scientific Corporation | $168.22 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $144.31 | 2019-2025 | Euflexxa |
| Foundation Fusion Solutions, LLC | $142.72 | 2024 | |
| Depuy Synthes Sales INC. | $130.03 | 2020-2022 | |
| Medtronic, INC. | $114.05 | 2021 | |
| Fidia Pharma USA INC. | $113.05 | 2019-2025 | Hyalgan |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.77 | 2021-2022 | |
| Orthogenrx INC. | $105.21 | 2019-2021 | |
| Terumo Bct, INC. | $51.93 | 2020-2021 | |
| Nevro Corp. | $43.87 | 2021 | |
| Vertos Medical, INC. | $39.65 | 2020-2024 | Mild Device Kit |
| Medline Industries LP | $37.54 | 2025 | |
| Scilex Pharmaceuticals INC. | $31.11 | 2020-2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtus Pharmaceuticals LLC | $29.60 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $28.93 | 2022-2023 | Seglentis |
| Zimvie INC. | $26.97 | 2022 | |
| Sanofi-Aventis U.S. LLC | $26.12 | 2019-2020 | |
| Horizon Therapeutics Plc | $25.04 | 2019 | |
| Curonix LLC | $17.49 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Protega Pharmaceutials INC | $14.23 | 2024 | Roxybond |
| Valinor Pharma, LLC | $14.04 | 2025 | Movantik |
| Zimmer Biomet Holdings, INC. | $13.67 | 2020 | |
| Medtronic USA, INC. | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Dorri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.